Holding(s) in Company
March 10 2008 - 5:30AM
UK Regulatory
RNS Number:7078P
Imaginatik PLC
10 March 2008
Form TR-1 with annex. FSA Version 2.1 updated April 2007
For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer of Imaginatik Plc
existing shares to which voting rights are attached:
2. Reason for notification (yes/no)
An acquisition or disposal of voting rights Yes
An acquisition or disposal of financial
instruments which may result in the acquisition
of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights
Other (please specify):______________
3. Full name of person(s) subject to notification Pfizer Inc.
obligation:
4. Full name of shareholder(s) (if different from Pfizer Inc.
3):
5. Date of transaction (and date on which the 06/03/2008
threshold is crossed or reached if different):
6. Date on which issuer notified: 07/03/2008
7. Threshold(s) that is/are crossed or reached: 6%
8: Notified Details
A: Voting rights attached to shares
Class/type of Situation previous to the Resulting situation after the triggering transaction
shares triggering transaction
If possible use
ISIN code
Number of Number of Number of Number of voting rights Percentage of voting
shares voting shares rights
rights
Direct Indirect Direct Indirect
GB00B1G2HX83 Less than Less than 8,035,885 8,035,885 6.45%
3% 3%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of voting
instrument period/date that may be acquired rights
(if the instrument
exercised/converted)
Total (A+B)
Number of voting rights Percentage of voting rights
8,035,885 6.45%
9. Chain of controlled undertakings through which the voting rights and /or the
financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14 Contact name: Roger J. Hill PhD
Worldwide Business Development| Pfizer Inc.| 50 Pequot
Ave.| New London CT 06320 | USA
Email: roger.j.hill@pfizer.com
15. Contact telephone name: Roger J. Hill PhD
Office: 860 732 2365;
fax: 860 732 7052
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLKBLBFVXBLBBQ
Abal (LSE:ABAL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Abal (LSE:ABAL)
Historical Stock Chart
From Jul 2023 to Jul 2024